Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine

In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Taweewun Hunsawong, Stefan Fernandez, Rome Buathong, Naretrit Khadthasrima, Kamonthip Rungrojchareonkit, Jindarat Lohachanakul, Rungarun Suthangkornkul, Kedsara Tayong, Angkana T. Huang, Chonticha Klungthong, Piyawan Chinnawirotpisan, Yongyuth Poolpanichupatam, Anthony R. Jones, Eric D. Lombardini, Supaporn Wacharapluesadee, Opass Putcharoen
Formato:	article
Lenguaje:	EN
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	coronavirus disease COVID 19 inactivated SARS-CoV-2 vaccine neutralizing antibodies respiratory infections SARS-CoV-2 Medicine R Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/368ae157e44542878ce19741b4c002e4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:368ae157e44542878ce19741b4c002e4
record_format	dspace
spelling	oai:doaj.org-article:368ae157e44542878ce19741b4c002e42021-11-22T12:58:59ZLimited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine10.3201/eid2712.2117721080-60401080-6059https://doaj.org/article/368ae157e44542878ce19741b4c002e42021-12-01T00:00:00Zhttps://wwwnc.cdc.gov/eid/article/27/12/21-1772_articlehttps://doaj.org/toc/1080-6040https://doaj.org/toc/1080-6059 In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate. Taweewun HunsawongStefan FernandezRome BuathongNaretrit KhadthasrimaKamonthip RungrojchareonkitJindarat LohachanakulRungarun SuthangkornkulKedsara TayongAngkana T. HuangChonticha KlungthongPiyawan ChinnawirotpisanYongyuth PoolpanichupatamAnthony R. JonesEric D. LombardiniSupaporn WacharapluesadeeOpass PutcharoenCenters for Disease Control and Preventionarticlecoronavirus diseaseCOVID 19inactivated SARS-CoV-2 vaccineneutralizing antibodiesrespiratory infectionsSARS-CoV-2MedicineRInfectious and parasitic diseasesRC109-216ENEmerging Infectious Diseases, Vol 27, Iss 12, Pp 3178-3180 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	coronavirus disease COVID 19 inactivated SARS-CoV-2 vaccine neutralizing antibodies respiratory infections SARS-CoV-2 Medicine R Infectious and parasitic diseases RC109-216
spellingShingle	coronavirus disease COVID 19 inactivated SARS-CoV-2 vaccine neutralizing antibodies respiratory infections SARS-CoV-2 Medicine R Infectious and parasitic diseases RC109-216 Taweewun Hunsawong Stefan Fernandez Rome Buathong Naretrit Khadthasrima Kamonthip Rungrojchareonkit Jindarat Lohachanakul Rungarun Suthangkornkul Kedsara Tayong Angkana T. Huang Chonticha Klungthong Piyawan Chinnawirotpisan Yongyuth Poolpanichupatam Anthony R. Jones Eric D. Lombardini Supaporn Wacharapluesadee Opass Putcharoen Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
description	In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.
format	article
author	Taweewun Hunsawong Stefan Fernandez Rome Buathong Naretrit Khadthasrima Kamonthip Rungrojchareonkit Jindarat Lohachanakul Rungarun Suthangkornkul Kedsara Tayong Angkana T. Huang Chonticha Klungthong Piyawan Chinnawirotpisan Yongyuth Poolpanichupatam Anthony R. Jones Eric D. Lombardini Supaporn Wacharapluesadee Opass Putcharoen
author_facet	Taweewun Hunsawong Stefan Fernandez Rome Buathong Naretrit Khadthasrima Kamonthip Rungrojchareonkit Jindarat Lohachanakul Rungarun Suthangkornkul Kedsara Tayong Angkana T. Huang Chonticha Klungthong Piyawan Chinnawirotpisan Yongyuth Poolpanichupatam Anthony R. Jones Eric D. Lombardini Supaporn Wacharapluesadee Opass Putcharoen
author_sort	Taweewun Hunsawong
title	Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
title_short	Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
title_full	Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
title_fullStr	Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
title_full_unstemmed	Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
title_sort	limited and short-lasting virus neutralizing titers induced by inactivated sars-cov-2 vaccine
publisher	Centers for Disease Control and Prevention
publishDate	2021
url	https://doaj.org/article/368ae157e44542878ce19741b4c002e4
work_keys_str_mv	AT taweewunhunsawong limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT stefanfernandez limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT romebuathong limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT naretritkhadthasrima limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT kamonthiprungrojchareonkit limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT jindaratlohachanakul limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT rungarunsuthangkornkul limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT kedsaratayong limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT angkanathuang limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT chontichaklungthong limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT piyawanchinnawirotpisan limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT yongyuthpoolpanichupatam limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT anthonyrjones limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT ericdlombardini limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT supapornwacharapluesadee limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine AT opassputcharoen limitedandshortlastingvirusneutralizingtitersinducedbyinactivatedsarscov2vaccine
_version_	1718417545627697152

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine

Ejemplares similares